Introducing the latest microphysiological system in our PhysioMimix™ OOC range - the PhysioMimix™ Single-organ Higher Throughput (HT) System - along with the groundbreaking Multi-chip Liver-48 Plate.
Our next-generation technology overcomes three adoption limitations, cost/chip, throughput and data confidence so that you can benefit from human-relevant insights earlier than ever before.
Through the careful miniaturization of our well-characterized human liver model, which recapitulates its functionality and microarchitecture, the solution facilitates larger-scale yet cost-effective comparative drug screening. Providing 48 chips in one SBS-standard footprint, the Liver-48 plate supports in-plate replicates, controls and 7-point dose responses for data robustness/ reproducibility.
Enabling multi-plate runs per system, this highly scalable solution brings game-changing throughput for predicting human drug safety and efficacy. It can be deployed for a variety of applications, including modeling Non-alcoholic steatohepatitis (NASH), Hepatitis B, drug-induced liver injury and drug metabolism/hepatic clearance.
#organonchip #lifescience #technologynews